NLRP3 and atherosclerosis: The demonstration that these crystals trigger the NLRP3 inflammasome and the release of inflammatory cytokines that also drive uric acid crystal-induced inflammation indicates that a drug effective in gout might be relevant in preventing inflammation and limiting injury in other disease including atherosclerosis (59).